$GGB

Gerdau S.A. Stock 12‑Month Price Target Raised to $5.44, Implies 4% Upside

Analysts raised Gerdau S.A.'s 12-month price target from $5.4 to $5.44, implying 4% upside from the Oct. 21 close. The consensus rating remains 'Buy' among 13 analysts, with 7 Buys and 6 Holds.

Original reporting
Published Oct 22, 2026, 10:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 10:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gerdau S.A. Stock 12‑Month Price Target Raised to $5.44, Implies 4% Upside — source image
Decision brief

The 30-second read

$GGBNeutralLow
01

Why it matters

Analyst consensus remains a Buy, but the incremental target lift suggests limited new information.

02

Market read

Small‑scale analyst target adjustment; unlikely to move the stock significantly.

03

What to watch

No new operational or financial data accompanies the target change.

Relevance 5/10Novelty 4/10Timing: immediate

Background

Gerdau is a leading steel producer with listings in Brazil and ADRs in the US.

Company-level read

Ticker impact

$GGBNeutralHigh confidence
Context

Analyst consensus price target for Gerdau was raised to $5.44, implying ~4% upside.

Expected impact

potential modest upside as investors price in the new target

Evidence & confidence

Target raise is small and reflects incremental optimism; no major catalyst beyond analyst opinion.

Market effects

Minor impact on the steel sector, limited to analyst sentiment.

Slight positive bias for Brazil‑listed steel producers.

Low; the change is company‑specific and not macro‑driven.

Counterpoint

The target raise is within the existing range and may already be priced in.

Key entities

  • Gerdau S.A.

    Brazilian steelmaker with US ADR GGB.

Related articles

$GGBMed

Gerdau (GGB) Q3 2026 Earnings Call Transcript

Gerdau S.A. reported Q3 2026 earnings, highlighting BRL 1.7B free cash flow, BRL 0.34/share dividends, and a solid balance sheet. The company expects to return over BRL 1.85B to shareholders in 2026. North American operations showed strong demand, while Brazil faced seasonal slowdowns and import challenges. The company plans adjustments to improve Brazilian profitability and is awaiting government support on trade and energy policies.

$GGBMed

What Gerdau (GGB) Said on Its Q3 Earnings Call

Gerdau (GGB) is expanding capacity at its Texas facility, with full production expected by 2027. The company focuses on organic investments, not spin-offs or major acquisitions. Management discussed potential trade impacts on regional margins. In Brazil, Gerdau faces import pressure but plans productivity improvements. The company announced dividends and reduced capital expenditure plans to BRL 4 billion. Net debt to EBITDA is 0.58 times, with a positive outlook from S&P.

$GGBMedAI 8/10

Gerdau ADR earnings missed, revenue topped estimates

Gerdau ADR (GGB) reported Q3 EPS of $0.159, missing estimates of $0.165, while revenue of $3.75B exceeded expectations. The stock is down 4.23% over 3 months but up 37.28% year-over-year. Analysts revised EPS positively twice in the last 90 days. InvestingPro rates its financial health as good.